Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Teva Pharmaceutical Industries
Manufacturing
Antheia seals 2nd series C funding close, hitting $175M
Biosynthesis specialist Antheia has topped off its series C funding with a second close, adding $24 million more to its haul.
Joseph Keenan
Jan 28, 2026 11:55am
JPM26, Day 2: Novo CEO talks 'mastering' cash pay sales in '26
Jan 13, 2026 7:29pm
Teva moves to delist 200-plus patents from FDA registry: FTC
Dec 10, 2025 4:58pm
Teva rides growth momentum through Q2, boosts '24 sales outlook
Jul 31, 2024 9:11am
Teva snares up to $150M in Abingworth funding for inhaler program
Apr 1, 2024 10:51am
Biogen notches another Tecfidera patent win in Europe
Dec 19, 2023 9:30am
